Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Chicago Crusader, The American Journal of Managed Care® (AJMC®), Pluang and Modern Healthcare. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 57d ago.
Quick answers
Why is "Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare covera" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (10)
- Eli Lilly Breaks Ground on $6.5B Generation Park Facility Yahoo Finance · 57d ago
- Eli Lilly Just Got a Big Boost From Medicare's GLP-1 Expansion GuruFocus · 57d ago
- Morning Business Report: Medicare obesity coverage drives GLP-1 use as Disney promotions boost park attendance 41NBC News · 57d ago
- Op-Ed: Kentucky cannot afford to ignore the obesity crises The Lane Report · 57d ago
- Medicare Spurs 700K Seniors to GLP-1s; Lilly Leads Briefs Finance · 57d ago
- State Medicaid program will now cover GLP-1 weight loss drugs The Chicago Crusader · 57d ago
- Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD The American Journal of Managed Care® (AJMC®) · 57d ago
- 700,000 seniors start GLP-1 obesity treatments under Medicare, 70% choose Eli Lilly drugs Pluang · 57d ago
- Medicare GLP-1 Bridge program a potential headwind for insurers Modern Healthcare · 57d ago
- Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs CNBC · 57d ago
Topics
Related trends
Home Depot names Richard McPhail as new CEO, beats earnings expectations
Home Depot appoints finance chief Richard McPhail as its new CEO while simultaneously reporting strong third-quarter earnings and sales beats.
'We feel blindsided': Minnesota seniors navigate unexpected Medicare cost increases
Medicare Advantage plan withdrawals and cost spikes are hitting seniors across multiple states ahead of 2027 enrollment changes.
A.I. Fueled Nvidia CEO Jensen Huang’s Elite Status, but Scandal Followed
Nvidia CEO Jensen Huang acknowledged an extramarital affair on November 8, 2026, as the company's board launched an independent investigation amid U.S. intelligence allegations linking a former Singapore executive to Beijing and Huang.
Quest Diagnostics pays $13M to settle kickback allegations involving NY Giants tickets
Quest Diagnostics has paid $13 million to settle a federal lawsuit alleging it used New York Giants perks to secure patient referrals.
Your job-based insurance cut GLP-1 coverage. Here are some options
Insurers are cutting coverage for GLP-1 weight-loss drugs, with coverage dropping from 57% to 53% between 2025 and 2026, while list prices range from $500 to over $1,000 monthly.
Nvidia opens investigation after reports CEO Jensen Huang was targeted by Chinese intelligence
Nvidia has launched an independent investigation of its CEO, Jensen Huang, over allegations he was targeted by Chinese intelligence.